US4962154A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Latex-antigen-antibody complexes for immunoassay
Assignee: Dow Chemical Co
•
Filing: 1988-07-14
•
Granted: 1990-10-09
•
Expires: 2008-07-14
Abstract
Abstract A latex partice comprising a vinyl aromatic monomer and an vinyl acrylate ester monomer which is modified by a protein binding modifying monomer to facilitate the binding of a protein via coupling techniques. These latex particles are useful in diagnostic test applications. The vinyl acrylate ester monomer and a vinyl aromatic monomer are dispersed in a ratio between 1:3 to 3:1 of vinyl acrylate ester monomer to vinyl aromatic monomer in an aqueous phase containing a protein binding modifying monomer. The protein modifying monomer can be a vinyl carboxylic acid, such as a acrylic acid in a concentration of from about 0.5 percent to about 10 percent of the monomers. The dispersion is subjected to emulsion polymerization to provide a latex particle in a size range from 0.1 to 1 micron. The latex particle is sensitized with an antibody or antigen via coupling techniques. The resulting sensitized latex particles combine attributes of each monomer to provide utility in difficult protein systems to form latex antigen/antibody complexes. The products of the invention may be used in a variety of diagnostic applications.
Inventors
- 👤 Douglas K. Pollock
- 👤 Charles J. McDonald
- 👤 William E. Cohrs
- 👤 John M. Reno
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-01 19:30
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/53; G01N33/543; G01N33/54313; C; C08; C08F; C08F212/00; C08F212/02; C08F212/04; C08F8/00; C08F8/04
Claims Analysis
Total Claims: 20
Claim 1
Independent Claim
98 words
A latex particle comprising a vinyl aromatic monomer selected from the group consisting of styrene, vinyl toluene, t-butyl styrene and mixtures thereof, a vinyl acrylate ester monomer having a pendent alkyl ester group of from 1 to 6 carbon atoms, wherein the vinyl aromatic monomer and vinyl acrylate ester monomer are employed in a weight ratio of about 1:3 to 3:1 vinyl acrylate ester to vinyl aromatic monomer, and a protein binding modifying monomer which is a vinyl carboxylic acid that is about 0.5 to about 10 weight percent of the vinyl aromatic and vinyl acrylate ester monomers.
Claim 2
Dependent Claim
98 words
A latex particle comprising a vinyl aromatic monomer selected from the group consisting of styrene, vinyl toluene, t-butyl styrene and mixtures thereof, a vinyl acrylate ester monomer having a pendent alkyl ester group of from 1 to 6 carbon atoms, wherein the vinyl aromatic monomer and vinyl acrylate ester monomer are employed in a weight ratio of about 1:3 to 3:1 vinyl acrylate ester to vinyl aromatic monomer, and a protein binding modifying monomer which is a vinyl carboxylic acid that is about 0.5 to about 10 weight percent of the vinyl aromatic and vinyl acrylate ester monomers.
Claim 3
Dependent Claim
24 words
A latex particle as in claim 1, wherein the vinyl aromatic monomer and vinyl acrylate ester monomer are employed in a ratio about 1:1.
Claim 4
Dependent Claim
25 words
A latex particle as in claim 1, wherein the vinyl acrylate ester is selected from the group consisting of methacrylate, n-butylacrylate, s-butylacrylate and mixtures thereof.
Claim 5
Dependent Claim
26 words
The latex particle as in claim 1, wherein the vinyl carboxylic acid is selected from the group consisting of acrylic acid, methylacrylic acid, and mixtures thereof.
Claim 6
Dependent Claim
27 words
The latex particle of claim 1, wherein the protein binding modifying monomer is employed in a concentration of about 1.0 to 3.0 weight percent of the copolymer.
Claim 7
Dependent Claim
18 words
The latex particle as in claim 1, wherein the said latex particle is about 0.1 to 1.0 micron.
Claim 8
Dependent Claim
19 words
The latex particle as in claim 1, wherein said latex particle is about 0.1800 micron to about 0.2000 micron.
Claim 9
Dependent Claim
34 words
A latex particle comprising a n-butylacrylate monomer and styrene monomer in a ratio of about 1:3 to 3:1 n-butylacrylate monomer to styrene monomer, which forms a copolymer and is used in diagnostic immunoassay applications.
Claim 10
Dependent Claim
34 words
A latex particle comprising a n-butylacrylate monomer and styrene monomer in a ratio of about 1:3 to 3:1 n-butylacrylate monomer to styrene monomer, which forms a copolymer and is used in diagnostic immunoassay applications.
Claim 11
Dependent Claim
23 words
The latex particle as in claim 8, wherein the n-butylacrylate monomer and styrene monomer are combined in a weight ratio of about 1:1.
Claim 12
Dependent Claim
48 words
The latex particle as in claim 9, wherein the latex particle is further modified by a protein binding modifying monomer which via coupling techniques, binds a protein to the latex particle, thereby sensitizing the latex particle so that said sensitized latex particle is used in diagnostic immunoassay applications.
Claim 13
Dependent Claim
17 words
The latex particle as in claim 10, wherein the protein binding modifying monomer is a carboxylic acid.
Claim 14
Dependent Claim
28 words
The latex particle as in claim 10, wherein the protein binding modifying monomer is employed in a concentration of about 0.5 to 10.0 weight percent of the copolymer.
Claim 15
Dependent Claim
28 words
The latex particle as in claim 12 wherein the protein binding modifying monomer is employed in a concentration of about 1.0 to 3.0 weight percent of the copolymer.
Claim 16
Dependent Claim
17 words
The latex particle as in claim 10, wherein said latex particle is about 0.1 to 1.0 micron.
Claim 17
Dependent Claim
17 words
The latex particle as in claim 14, wherein said latex particle is about 0.18 to 0.20 micron.
Claim 18
Dependent Claim
54 words
A latex particle comprising a vinyl aromatic monomer, a vinyl acrylate ester monomer and a protein binding modifying monomer, wherein said protein binding modifying monomer which is a vinyl carboxylic acid couples a protein to said latex particle, thereby sensitizing the latex particle so that said latex particle is used in diagnostic immunoassay applications.
Claim 19
Dependent Claim
54 words
A latex particle comprising a vinyl aromatic monomer, a vinyl acrylate ester monomer and a protein binding modifying monomer, wherein said protein binding modifying monomer which is a vinyl carboxylic acid couples a protein to said latex particle, thereby sensitizing the latex particle so that said latex particle is used in diagnostic immunoassay applications.
Claim 20
Dependent Claim
20 words
The sensitized latex as in claim 16, wherein the protein is coupled to the latex particle via the carbodiimide technique.
References Cited (Backward Citations)
US4094841A
Cited
US4060597A
Cited
US4080264A
Cited
US4046723A
Cited
US4045384A
Cited
US4210723A
Cited
US4421896A
Cited
US4559303A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1993-10-08 | 1994-04-09 | 1994-10-09 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1997-10-08 | 1998-04-09 | 1998-10-09 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2001-10-08 | 2002-04-09 | 2002-10-09 | $7700.00 | Window Closed / Lapsed |